Gastroparesis Clinical Trials

19 studies are recruiting for gastroparesis in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Louisville, Kentucky 6 Indianapolis, Indiana 4 Philadelphia, Pennsylvania 4 Boston, Massachusetts 3 Columbus, Ohio 3 Scottsdale, Arizona 3

Studies now recruiting

  1. The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM

    The purpose of this study is to investigate whether or not the investigators can utilize Body Surface Gastric Mapping to determine who would best benefit to receive G-POEM procedure and how Body Surface Gastric Mapping can be utilized with patients who have gastroparesis symptoms. the investigators…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Indiana University Health University Hospital, Indianapolis, Indiana
    Run by
    Indiana University

    See if you can join NCT06493032 on ClinicalTrials.gov

  2. Virtual Poetry Workshops to Enhance Patient Well Being and Reduce Anxiety

    This study examines whether participating in poetry workshops can improve emotional well-being among patients with chronic digestive symptoms. Many individuals with long-standing digestive conditions experience distress, anxiety, isolation, and difficulty expressing their emotions in clinical setti…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Ohio State University Wexner Medical Center, Columbus, Ohio
    Run by
    Ohio State University

    See if you can join NCT07717541 on ClinicalTrials.gov

  3. GI Neuromuscular Pathology Prospective Registry

    In this research study, biopsy samples will be collected to provide more insight into the underlying cause of the motility disorders, help direct further investigation into the cause of the underlying condition, provide future prognosis and predict response to gastric electrical stimulation (GES).

    Stage
    Not phased
    Ages
    0 to 90
    Site
    Indiana University Hosptial, Indianapolis, Indiana
    Run by
    Indiana University

    See if you can join NCT02165059 on ClinicalTrials.gov

  4. Indiana University Gastrointestinal Motility Diagnosis Registry

    Develop a registry (list of patients) with accurate clinical motility diagnosis. This registry will help the doctors to identify the patients with specific disease conditions. It will also help in promoting future research in gastroenterology motility disorders

    Stage
    Not phased
    Ages
    Any age
    Site
    Indiana University Health University Hospital, Indianapolis, Indiana
    Run by
    Indiana University

    See if you can join NCT04506593 on ClinicalTrials.gov

  5. Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects

    Functional dyspepsia and gastroparesis are common stomach disorders with symptoms like early satiety, nausea, and abdominal pain, and are often evaluated with gastric emptying tests, although the correlation with symptoms is weak. Prokinetic agents (e.g., metoclopramide, erythromycin) and symptom m…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Western Sydney University, Sydney, New South Wales
    Locations
    3 in total
    Run by
    University of Auckland, New Zealand

    See if you can join NCT06854120 on ClinicalTrials.gov

  6. Gastroparesis Outcome Longitudinal Database Enrolled Numerically

    GOLDEN is a longitudinal database of patients with the symptoms (Sx) of gastroparesis (Gp) who were seen and recorded at the University of Louisville from 2012 and is ongoing. Patients are enrolled and followed by sequential numbers and may include legacy patients seen at other centers by some of t…

    Stage
    Not phased
    Ages
    Any age
    Site
    University of Louisville, Louisville, Kentucky
    Run by
    University of Louisville

    See if you can join NCT03876288 on ClinicalTrials.gov

  7. Growth Hormone for the Treatment of Gastroparesis

    The purpose of this study is to determine whether treatment with Growth Hormone results in symptomatic improvement in patients with gastroparesis.

    Stage
    EARLY_Phase 1
    Ages
    18 to 65
    Site
    Mayo Clinic, Phoenix, Arizona
    Locations
    2 in total
    Run by
    Mayo Clinic

    See if you can join NCT06803589 on ClinicalTrials.gov

  8. Domperidone in Treating Patients With Gastrointestinal Disorders

    This phase III trial studies how well domperidone works in treating patients with gastrointestinal disorders. Domperidone may help control chronic gastrointestinal disorders and their symptoms, such as pain, bloating, and nausea and vomiting, by stimulating contraction of the stomach to increase it…

    Stage
    Phase 3
    Ages
    16 and older
    Site
    M D Anderson Cancer Center, Houston, Texas
    Run by
    M.D. Anderson Cancer Center

    See if you can join NCT01696734 on ClinicalTrials.gov

  9. Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms

    The overall objective of this study is to determine if there are pyloric sphincter abnormalities in patients with gastroparesis symptoms and determine how prevalent these abnormalities are using tests to assess the pyloric sphincter - endoluminal functional luminal imaging probe (Endoflip™), water …

    Stage
    Not phased
    Ages
    18 to 85
    Site
    Mayo Clinic Arizona, Scottsdale, Arizona
    Locations
    5 in total
    Run by
    Johns Hopkins Bloomberg School of Public Health

    See if you can join NCT04661215 on ClinicalTrials.gov

  10. Gastroparesis Registry 4

    The Gastroparesis Registry 4 (GpR4) is an observational study of patients with symptoms of gastroparesis (Gp) and functional dyspepsia (FD) with either delayed or normal gastric emptying. To better understand these disorders, this registry will capture demographic, clinical, physiological, question…

    Stage
    Not phased
    Ages
    18 to 85
    Site
    Jay Pasricha, Scottsdale, Arizona
    Locations
    6 in total
    Run by
    Johns Hopkins Bloomberg School of Public Health

    See if you can join NCT05846802 on ClinicalTrials.gov

  11. GpCRC Pediatric Gastroparesis Registry 2

    The objective of the Pediatric Gastroparesis Registry 2 is to create a national prospective registry of children, adolescents, and young adults with gastroparesis and gastroparesis-like syndrome (symptoms of gastroparesis but normal gastric emptying).

    Stage
    Not phased
    Ages
    8 to 25
    Site
    Massachusetts General Hospital, Boston, Massachusetts
    Locations
    6 in total
    Run by
    Johns Hopkins Bloomberg School of Public Health

    See if you can join NCT05981300 on ClinicalTrials.gov

  12. Study of Gastric Motility in Eosinophilic Gastritis

    Purpose: The study is a cross-sectional observational study designed to determine if eosinophilic gastritis (EG) results in gastric motility impairment. Hypothesis: Gastric dysfunction occurs in the natural history of EG but is underdiagnosed due, in part, to contraindications to the use of the sta…

    Stage
    Not phased
    Ages
    18 to 59
    Site
    Northwestern University, Chicago, Illinois
    Locations
    3 in total
    Run by
    Children's Hospital Medical Center, Cincinnati

    See if you can join NCT05229432 on ClinicalTrials.gov

  13. Compassionate Use of Domperidone for Refractory Gastroparesis

    The purpose of this program is to allow the use of domperidone in children from 12 to 21 years of age with symptoms related to motility disorders and Gastroesophageal reflux disease (GERD) who have failed all the standard treatments for their condition.

    Stage
    Not phased
    Ages
    12 to 21
    Site
    Children's Mercy Hospitals and Clinics, Kansas City, Missouri
    Run by
    Jose Cocjin

    See if you can join NCT04699591 on ClinicalTrials.gov

  14. Gastric Per-Oral Endoscopic Myotomy (G-POEM) for the Treatment of Gastroparesis

    Gastric Per-Oral Endoscopic Myotomy (G-POEM) is a procedure for the Treatment of Gastroparesis.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Indiana University Hospital, Indianapolis, Indiana
    Run by
    Indiana University

    See if you can join NCT04434781 on ClinicalTrials.gov

  15. BSGM to Evaluate Patients With GI Symptoms

    The goal of this observational study is to learn about gastric myoelectric activity in children with GI symptoms. The main question it aims to answer is which patterns or signals are associated with GI symptoms as measured by a body surface gastric mapping (BSGM) device. Participants will have thei…

    Stage
    Not phased
    Ages
    8 to 25
    Site
    Alliant International University, San Diego, California
    Locations
    5 in total
    Run by
    Children's Hospital of Philadelphia

    See if you can join NCT05880199 on ClinicalTrials.gov

  16. Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders

    This is prospective data recording study. All patients will receive standard medical care and no experimental interventions will be performed.

    Stage
    Not phased
    Ages
    18 and older
    Site
    AdventHealth Orlando, Orlando, Florida
    Run by
    AdventHealth

    See if you can join NCT05905016 on ClinicalTrials.gov

  17. IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy

    Patients with the symptoms of generalized GI dysmotility, including gastroparesis, are sometimes refractory to available medications, devices and other interventions/ Some of these patients have serologic and/or endo organ abnormalities and findings consistent with autoimmune neuropathies, primaril…

    Stage
    Not phased
    Ages
    12 to 90
    Site
    University of Louisville, Louisville, Kentucky
    Run by
    University of Louisville

    See if you can join NCT04208828 on ClinicalTrials.gov

  18. Study of Enterra Programming with Nocturnal Cycling in Gastroparetics

    The purpose of this research study is to evaluate if different Enterra® device programming methods active during sleeping hours can maintain gastroparesis-related symptom relief and quality of life measures. Participants in this study with existing Enterra® devices will be randomly assigned to one …

    Stage
    Not phased
    Ages
    18 to 70
    Site
    University of Louisville, Louisville, Kentucky
    Locations
    2 in total
    Run by
    Enterra Medical, Inc.

    See if you can join NCT05980455 on ClinicalTrials.gov

  19. Study of Enhanced Programming Stimulation with the Enterra® Therapy System

    The purpose of this research study is to evaluate if an enhanced Enterra device programming strategy will improve symptoms associated with gastroparesis, improve symptoms in a faster amount of time, and improve quality of life measures. Participants in this study will be evaluated for study entry c…

    Stage
    Not phased
    Ages
    18 to 70
    Site
    University of South Florida, Tampa, Florida
    Locations
    6 in total
    Run by
    Enterra Medical, Inc.

    See if you can join NCT06560307 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.